Published Date : Dec 13, 2016
ALBANY, NY, Dec 13, 2016: The report, titled “Infectious Disease Point of Care Testing - Current and Future Players,” is a comprehensive reports of players that are currently operating and emerging in the highly fragmented market for infectious disease point-of-care testing (POCT). It identifies the strategies that the key players are employing to gain ground in the competitive market, which includes more than 100 players. The report also detects the industry trends as well as gives out information on recent mergers, acquisitions, and key partnerships.
Point-of-care testing refers to the medical diagnostics performed in the proximity of the patients rather than at clinical laboratories. POCT eliminates the waiting period of sending off specimens away from the point of care and receiving the results. These results help build an electronic medical record of the patient and can be shared instantaneously with other members of the medical team through the software interface, thereby enhancing the experience by decreasing the turnaround time (TAT). Other benefits of point-of-care testing includes reduced postoperative care time, shortened emergency room time, fewer clinical visits for outpatients, and reduction in the number of hospital beds required. It also optimizes the time of healthcare professionals.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/879228
The report finds that the infectious disease POCT market is highlighted by a variety of products offered by several players, and the aggressive marketing strategies adopted. As a result, the competition is growing and the pricing is intense. Multinational companies and financially sound regional players are investing heavily in new technologies and innovative products. The report observes that the competitive landscape of the global infectious disease point-of-care testing market is also fueled by several other factors such as fast turnaround time of test results, price and reimbursement, analytical performance, research and development, data handling techniques, marketing, promotion, and brand name recognition of the respective companies.
One of the key features of the report is its section on company profiles, wherein it provides up-to-date information and in-depth reports on the leading players operating in the global market for infectious disease point-of-care testing. The prominent players profiled in the report are Alere, Beckman Coulter, BioMerieux, Cepheid, Chembio Diagnostics, Meridian Bioscience, OraSure Technologies, Quidel, Roche Diagnostics, and Trinity Biotech. For each of these companies, marketed product assessments and SWOT reports has been provided. The report also studies companies operating in regional infectious disease POCT markets such as North America, Europe, and Asia Pacific.
The section on pipeline assessment identifies the drugs that are in early development, pre-clinical, and clinical stages or are awaiting approval. It also provides figures pertaining to the global infectious disease POCT market by company share, pipeline drugs by the stage of development, and physician survey count by country.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org